BrainsWay(BRSYF)

Focus: BrainsWay is a public neurotechnology company founded in 2003 that develops Deep Transcranial Magnetic Stimulation (dTMS) devices for treating brain disorders, with a focus on neuropsychiatric and neurological indications.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About BrainsWay

AI assessmentNot Hiring

No open roles listed right now. Follow BrainsWay to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

BrainsWay Deep TMS System

Major Depressive Disorder

Growth

FDA-cleared lead indication with multiple Phase 2–4 programs validating dTMS mechanism across depression subtypes and combination therapy.

Pipeline & Clinical Trials

Help build intelligence for BrainsWay

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established medical device player (public since 2003) with FDA-cleared platform technology (dTMS) generating commercial revenue in psychiatric disorders
Extensive pipeline of 30 clinical programs across Phase 1–4 studies, with indications spanning depression, OCD, Alzheimer's, autism, and PTSD offering diverse scientific exposure
Device-based approach creates non-traditional pharma career paths in biomedical engineering, regulatory affairs, and neuromodulation—differentiating skill development vs. traditional drug development

Watch Out For

Zero active job openings reported despite public status and active clinical pipeline suggests limited near-term hiring or potential organizational headcount constraints
No revenue, cash position, or R&D spend data publicly disclosed in materials—opacity on financial stability and runway makes long-term employment security unclear

Generated by Claude from BrainsWay's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Magstim Rapid2 Stimulator

Healthy

N/A

Clinical Trials (1)

NCT01041300The Effects of Trancranial Magnetic Stimulation Multichannel Stimulator on Motor Excitation

N/A

repetitive Transcranial Magnetic Stimulation

Healthy

N/A

Clinical Trials (1)

NCT02212405Does the Insula Control Smoking-Induced Dopamine Release? A TMS/[11C]-PHNO Study in Humans.

N/A

BrainsWay Deep TMS HAC/H7-Coil

Obsessive-Compulsive Disorder

N/A

Clinical Trials (1)

NCT07116785Accelerated Rotational Field Deep TMS for Treating OCD

N/A

repetitive transcranial stimulation

Asymmetric Parkinson's Disease

N/A

Clinical Trials (1)

NCT01367782A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease

N/A

BrainsWay Deep TMS HAC/H7-Coil

Obsessive-Compulsive Disorder

N/A

Clinical Trials (1)

NCT05404360Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects

N/A

CBT-based, mobile-delivered, intervention platform

Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment

N/A

Clinical Trials (1)

NCT04455646Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

N/A

Deep TMS

Obsessive Compulsive Disorder

N/A

Clinical Trials (1)

NCT01343732Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects

N/A

Brainsway Multiway deep TMS device

Parkinson

N/A

Clinical Trials (1)

NCT02249715Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease

N/A

Active DTMS Treatment

Obsessive Compulsive Disorder

N/A

Clinical Trials (1)

NCT02229903An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

N/A

H-coil

Multiple Sclerosis

N/A

Clinical Trials (1)

NCT01106365Repetitive Deep Transcranial Magnetic Stimulation in Multiple Sclerosis

N/A

5 channels Multiway deep Transcranial Magnetic Stimulator

Depression

N/A

Clinical Trials (1)

NCT01501825A Prospective, Comparative Study to Explore the Efficacy and Safety of the Five Channels Multiway Deep Transcranial Magnetic Stimulation (TMS) Device in Subjects With Major Depression Disorder (MDD)

N/A

Deep Brain Transcranial Magnetic Stimulation

Bipolar Depression

N/A

Clinical Trials (1)

NCT01962350Treatment of Bipolar Depression With H1-Coil Deep Brain rTMS: Clinical-Cognitive and Safety Evaluation

N/A

Deep TMS Treatment

Bipolar Depression

N/A

Clinical Trials (1)

NCT01566591Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

N/A

dTMS

Depression

N/A

Clinical Trials (1)

NCT02260765Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual

N/A

Deep Repetitive Transcranial Magnetic Stimulation

Tobacco Use Disorder

N/A

Clinical Trials (1)

NCT04083144Deep rTMS and Varenicline for Smoking Cessation

N/A

H-Coil Deep TMS in combination with SSRIs

Major Depressive Disorder, Recurrent, Unspecified

N/A

Clinical Trials (1)

NCT01361815Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)

N/A

Brainsway Deep TMS System

Major Depressive Disorder

N/A

Clinical Trials (1)

NCT06357832New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)

N/A

H-Coil deep TMS

Bipolar Depression

N/A

Clinical Trials (1)

NCT00657735Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression

N/A

Deep TMS

Alcohol Use Disorder

N/A

Clinical Trials (1)

NCT07216872Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)

N/A

H7-Coil

Major Depressive Disorder (MDD)

N/A

Clinical Trials (1)

NCT03012724Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)

N/A

Brainsway H1-Coil Deep TMS System

Major Depressive Disorder

N/A

Clinical Trials (1)

NCT03665831Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

N/A

Deep Insula-coil rTMS

Anorexia Nervosa

N/A

Clinical Trials (1)

NCT03144986Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa

N/A

Active Brainsway H7-Coil Deep TMS System

Alzheimer Disease

N/A

Clinical Trials (1)

NCT06095063dTMS for Subjective Cognitive Decline

N/A

Deep TMS System

Post-Traumatic Stress Disorder

N/A

Clinical Trials (1)

NCT02479906A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)

N/A

Brainsway H1-Coil Deep TMS System

Major Depressive Disorder

N/A

Clinical Trials (1)

NCT01860157Deep rTMS for Treatment-Resistant Late-life Depression

N/A

Brainsway H-Coil Deep TMS System

Major Depressive Disorder

N/A

Clinical Trials (1)

NCT00927173Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder

N/A

TMS

Effect of Deep Transcranial Magnetic Stimulation on Memory

PHASE_1

Clinical Trials (1)

NCT01599208Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe

Phase 1

Transcranial Direct Current Stimulation

Adult Attention Deficit Disorder

PHASE_1

Clinical Trials (1)

NCT02206516Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD).

Phase 1

H1 and H2 deep TMS coils

Major Depression

PHASE_1

Clinical Trials (1)

NCT00445237Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression

Phase 1

H-Coil Deep TMS

Mild Cognitive Impairment

PHASE_1

Clinical Trials (1)

NCT01464515Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment

Phase 1

treatment by HLPFC coil

Attention Deficit Hyperactivity Disorder

PHASE_1

Clinical Trials (1)

NCT01196910Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults

Phase 1

Deep Transcranial Magnetic Stimulation

Tinnitus

PHASE_2

Clinical Trials (1)

NCT02053961Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus.

Phase 2

Transcranial Magnetic Stimulation

Autism

PHASE_2

Clinical Trials (1)

NCT01388179Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.

Phase 2

Deep TMS

Machado Joseph Disease (SCA3)

PHASE_2

Clinical Trials (1)

NCT02039206The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease

Phase 2

TMS, H coil

Alzheimer's Disease

PHASE_2

Clinical Trials (1)

NCT01179373Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease

Phase 2

H-coil dTMS

Major Depressive Disorder

PHASE_2

Clinical Trials (1)

NCT00807105Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode

Phase 2

1Hz TMS with H2 coil

Alzheimer's Disease

PHASE_2

Clinical Trials (1)

NCT00753662Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease

Phase 2

Deep Transcranial Magnetic Stimulation

Major Depressive Disorder

PHASE_2_3

Clinical Trials (1)

NCT01409304Effectiveness of Deep Transcranial Magnetic Stimulation in Depression

Phase 2/3

Deep Transcranial Magnetic Stimulation

Major Depressive Disorder

PHASE_2_3

Clinical Trials (1)

NCT01409317Neural Predictors and Longitudinal Neural Correlates of Deep Transcranial Magnetic Stimulation for Treating Major Depression

Phase 2/3

Sham Treatment

Smoking Cessation

PHASE_3

Clinical Trials (1)

NCT02126124Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.

Phase 3

Brainsway DTMS with intermittent Theta Burst Stimulation

Major Depressive Disorder

PHASE_4

Clinical Trials (1)

NCT04679753Brainsway DTMS for Treatment of MDD Using iTBS

Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2003

Portfolio: 41 clinical trials

Top TAs: Neurology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Neurology

13 pipeline

Marketed

Pipeline